ibandronate sodium


Also found in: Dictionary.

ibandronate sodium

(ī-băn′drə-nāt′)
n.
A bisphosphonate drug that inhibits bone resorption, given monthly to treat and prevent osteoporosis primarily in postmenopausal women.
References in periodicals archive ?
Reddy's Laboratories (NYSE: RDY) announced today that it has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of BONIVA([R])tablets in the US market on June 29, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr.
announced today that ibandronate sodium hydrate (generic name) oral agent demonstrated non-inferiority in efficacy of increasing the bone mass of the lumbar spine compared to a comparator, ibandronate sodium hydrate injection.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ibandronate Sodium Tablets, 150mg.
announced today that they launched the ibandronate sodium hydrate, a bisphosphonate antiresorptive agent brand name: Bonviva Injection 1 mg Syringe (hereafter, Bonviva IV Injection ) , for the indication of osteoporosis on August 29, 2013.